General
Preferred name
GTS-21
Synonyms
DMBX-anabaseine ()
DMXB-A ()
GTS 21 dihydrochloride ()
GTS-21 (dihydrochloride) ()
DMXB-ANABASEINE ()
Dmxb-a ()
3-(2,4-Dimethoxybenzylidene)Anabaseine ()
Dimethoxybenzylidene anabaseine ()
GTS-21 (hydrochloride) ()
P&D ID
PD016145
CAS
156223-05-1
148372-04-7
Tags
available
drug candidate
Drug indication
Parkinson disease
Drug Status
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION GTS-21 (DMBX-A), is a novel, small-molecule, orally active and selective α7 nicotinic acetylcholine (nACh) receptor agonist, that has been advanced to clinical evaluation in a range of conditions . There is a report that the anti-inflammatory effects of GTS-21 may be in part due to α7 nACh receptor-independent activity . (GtoPdb)
Cell lines
0
Organisms
1
Compound Sets
13
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
TargetMol Bioactive Compound Library
External IDs
34
Properties
(calculated by RDKit )
Molecular Weight
308.15
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
3
Aromatic Ring Count
2
cLogP
3.77
TPSA
43.71
Fraction CSP3
0.26
Chiral centers
0.0
Largest ring
6.0
QED
0.86
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Neuroscience
GPCR/G protein
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
??4??2 nAChR
¦Á4¦Â2 nAChR
CHRNA7
a7 partial agonist
5-HT Receptor
nAChR
MOA
AChR agonist
Nicotinic alpha7 Partial Agonists
cholinergic receptor agonist
Member status
member
Source data